136 related articles for article (PubMed ID: 36555852)
1. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract][Full Text] [Related]
2. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas.
Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
[TBL] [Abstract][Full Text] [Related]
3. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).
Jurutka PW; Kaneko I; Yang J; Bhogal JS; Swierski JC; Tabacaru CR; Montano LA; Huynh CC; Jama RA; Mahelona RD; Sarnowski JT; Marcus LM; Quezada A; Lemming B; Tedesco MA; Fischer AJ; Mohamed SA; Ziller JW; Ma N; Gray GM; van der Vaart A; Marshall PA; Wagner CE
J Med Chem; 2013 Nov; 56(21):8432-54. PubMed ID: 24180745
[TBL] [Abstract][Full Text] [Related]
4. Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).
Furmick JK; Kaneko I; Walsh AN; Yang J; Bhogal JS; Gray GM; Baso JC; Browder DO; Prentice JL; Montano LA; Huynh CC; Marcus LM; Tsosie DG; Kwon JS; Quezada A; Reyes NM; Lemming B; Saini P; van der Vaart A; Groy TL; Marshall PA; Jurutka PW; Wagner CE
ChemMedChem; 2012 Sep; 7(9):1551-66. PubMed ID: 22927238
[TBL] [Abstract][Full Text] [Related]
5. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.
Hanish BJ; Hackney Price JF; Kaneko I; Ma N; van der Vaart A; Wagner CE; Jurutka PW; Marshall PA
Steroids; 2018 Jul; 135():36-49. PubMed ID: 29704526
[TBL] [Abstract][Full Text] [Related]
6. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
Leal AS; Hung PY; Chowdhury AS; Liby KT
Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
[TBL] [Abstract][Full Text] [Related]
7. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
[TBL] [Abstract][Full Text] [Related]
8. The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation
Gaunt CM; Rainbow DB; Mackenzie RJ; Jarvis LB; Mousa HS; Cunniffe N; Georgieva Z; Brown JW; Coles AJ; Jones JL
Front Immunol; 2021; 12():712241. PubMed ID: 34447379
[TBL] [Abstract][Full Text] [Related]
9. Oral retinoids and rexinoids in cutaneous T-cell lymphomas.
Sokołowska-Wojdyło M; Lugowska-Umer H; Maciejewska-Radomska A
Postepy Dermatol Alergol; 2013 Feb; 30(1):19-29. PubMed ID: 24278042
[TBL] [Abstract][Full Text] [Related]
10. The multi-faceted role of retinoid X receptor in bone remodeling.
Menéndez-Gutiérrez MP; Ricote M
Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
[TBL] [Abstract][Full Text] [Related]
11. The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.
Reich LA; Moerland JA; Leal AS; Zhang D; Carapellucci S; Lockwood B; Jurutka PW; Marshall PA; Wagner CE; Liby KT
Sci Rep; 2022 Jan; 12(1):293. PubMed ID: 34997154
[TBL] [Abstract][Full Text] [Related]
12. Effect of LXR/RXR agonism on brain and CSF Aβ40 levels in rats.
Wang S; Wen P; Wood S
F1000Res; 2016; 5():138. PubMed ID: 27239272
[TBL] [Abstract][Full Text] [Related]
13. Bexarotene drives the self-renewing proliferation of adult neural stem cells, promotes neuron-glial fate shift, and regulates late neuronal differentiation.
Saibro-Girardi C; Scheibel IM; Santos L; Bittencourt RR; Fröhlich NT; Dos Reis Possa L; Moreira JCF; Gelain DP
J Neurochem; 2023 Nov; ():. PubMed ID: 37984072
[TBL] [Abstract][Full Text] [Related]
14. Ligand Screening System for the RXRα Heterodimer Using the Fluorescence RXR Agonist CU-6PMN.
Kawasaki M; Motoyama T; Yamada S; Watanabe M; Fujihara M; Kambe A; Nakano S; Kakuta H; Ito S
ACS Med Chem Lett; 2023 Mar; 14(3):291-296. PubMed ID: 36923911
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models.
Leal AS; Zydeck K; Carapellucci S; Reich LA; Zhang D; Moerland JA; Sporn MB; Liby KT
NPJ Breast Cancer; 2019; 5():39. PubMed ID: 31700995
[TBL] [Abstract][Full Text] [Related]
16. Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism.
Zaienne D; Isigkeit L; Marschner JA; Duensing-Kropp S; Höfner G; Merk D
ChemMedChem; 2023 Nov; 18(21):e202300404. PubMed ID: 37697963
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties.
Lewandowski M; Carmina M; Knümann L; Sai M; Willems S; Kasch T; Pollinger J; Knapp S; Marschner JA; Chaikuad A; Merk D
J Med Chem; 2024 Feb; 67(3):2152-2164. PubMed ID: 38237049
[TBL] [Abstract][Full Text] [Related]
18. Dietary Phenolic Compounds Exert Some of Their Health-Promoting Bioactivities by Targeting Liver X Receptor (LXR) and Retinoid X Receptor (RXR).
Domínguez-Avila JA
Foods; 2023 Nov; 12(23):. PubMed ID: 38231664
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of [(11)C]Bexarotene by Cu-Mediated [(11)C]Carbon Dioxide Fixation and Preliminary PET Imaging.
Rotstein BH; Hooker JM; Woo J; Collier TL; Brady TJ; Liang SH; Vasdev N
ACS Med Chem Lett; 2014 Jun; 5(6):668-72. PubMed ID: 24944741
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Potent Retinoid X Receptor Antagonist Structurally Closely Related to RXR Agonist NEt-3IB.
Nakayama M; Yamada S; Ohsawa F; Ohta Y; Kawata K; Makishima M; Kakuta H
ACS Med Chem Lett; 2011 Dec; 2(12):896-900. PubMed ID: 24900278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
